GSK Exercises Option to Progress Deve...

GSK Exercises Option to Progress Development of ChemoCentryx's...

There are 2 comments on the Applied Clinical Trials story from Jan 11, 2010, titled GSK Exercises Option to Progress Development of ChemoCentryx's.... In it, Applied Clinical Trials reports that:

GSK Exercises Option to Progress Development of ChemoCentryx's Traficet-EN for the Treatment of Inflammatory Bowel Diseases LONDON and MOUNTAIN VIEW, Calif., Jan.

Join the discussion below, or Read more at Applied Clinical Trials.

roberta

Rio De Janeiro, Brazil

#1 Jan 28, 2010
vn v vmnb
Bill

Toronto, Canada

#2 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

ChemoCentryx Discussions

Title Updated Last By Comments
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News GSK licenses experimental arthritis treatment f... (May '12) May '12 Robson 1
News GSK Licenses RA Drug from ChemoCentryx (May '12) May '12 Robson 1
News GSK Exercises Option to License ChemoCentryx's ... (May '12) May '12 Robson 1
News GlaxoSmithKline Exercises Option to License Che... (May '12) May '12 Joan 1
News GSK obtains exclusive license to ChemoCentryx's... (May '12) May '12 Joan 1
News Drug developer ChemoCentryx has priced its IPO ... (May '12) May '12 Joan 1
More from around the web